Better Understanding in the Differentiation of Thyroid Follicular Adenoma, Follicular Carcinoma, and Follicular Variant of Papillary Carcinoma: A Retrospective Study by 怨쎌쭊�쁺 et al.
Clinical Study
Better Understanding in the Differentiation of Thyroid
Follicular Adenoma, Follicular Carcinoma, and Follicular
Variant of Papillary Carcinoma: A Retrospective Study
Jung Hyun Yoon, Eun-Kyung Kim, Ji Hyun Youk, Hee Jung Moon, and Jin Young Kwak
Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine,
50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea
Correspondence should be addressed to Jin Young Kwak; docjin@yuhs.ac
Received 9 January 2014; Accepted 8 September 2014; Published 18 September 2014
Academic Editor: Constantinos Pantos
Copyright © 2014 Jung Hyun Yoon et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Background. To evaluate the role of ultrasonography (US), US-guided fine-needle aspiration (USFNA) and intraoperative frozen
section (FS) in follicular neoplasm.Methods. US features, USFNA cytology, and FS results were compared based on the pathology
results of patients with follicular adenoma (FA), follicular carcinoma (FC), and follicular variant of papillary thyroid carcinoma
(FVPTC). Results. FC and FVPTC showed significantly higher rates of suspicious US features (𝑃 < 0.05) and positive findings on
either US or cytology, 80.0% and 90.7%, compared to FA, 64.5% (𝑃 = 0.001). Intraoperative FS showed higher malignant rates
in FVPTC and FC (81.8% and 75.0%, resp.), compared to FA (3.8%, 𝑃 < 0.001). Conclusion. Suspicious US features were more
significantly seen in FC and FVPTC compared to FA. Intraoperative FS is useful in the differential diagnosis of these lesions and
supplements cytology results of USFNA.
1. Introduction
Thyroid nodules showing follicular morphologic features
include adenomatous nodule, follicular adenoma (FA), follic-
ular carcinoma (FC), and follicular variant of papillary thy-
roid carcinoma (FVPTC) [1]. Cytologic features are known
to overlap among these tumors [2, 3], and definite diagnosis
of FA, FC, and FVPTC is mostly obtained by pathologic
examination following complete excision of the lesion [1, 4, 5].
The diagnosis of a solitary, encapsulated nodule with
follicular histology features is frequently problematic since
a broad range of benign to malignant subtypes of follicular
tumors need to be differentiated, such as FA, FC, and
FVPTC [6]. Differential diagnosis of FC from FA is based
on the presence of capsular, vascular, or extrathyroidal tissue
invasion, and nodal or distant metastasis [4, 6, 7]. Diagnosis
of follicular neoplasm based on cytology alone has always
been challenging to both clinicians and cytopathologists,
since it is well known that cytologic features overlap in both
benign follicular adenoma and carcinomas [2, 3, 8, 9]. Studies
have investigated ways in providing additional information
that may be helpful in differential diagnosis and surgical
planning of follicular neoplasm [4, 6, 10, 11] but controversy
still remains and clinicians are still skeptical until they see the
conclusive reports on permanent section.
Diagnostic criteria for the cytologic diagnosis of FVPTC
are in general similar to those of PTC, that is, cells contain-
ing fine chromatic, nuclear grooves, intranuclear inclusions,
and overlapping nuclei [12–15], but FVPTC lacks papillary
groups and shows follicular patterns with variable colloid
component, which can also be seen in benign and neoplastic
follicular lesions [1, 13].This overlapmakes accurate cytologic
diagnosis difficult in FVPTC and results in the low sensitivity
(25% to 42%) of fine-needle aspiration (FNA) in the diagnosis
of FVPTC, compared to conventional papillary carcinoma
(sensitivity range from 60% to over 90%) [13–15].
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False-negative cytologic results are also occasionally
observed, for example, follicular carcinomas containing ma-
crofollicular pattern with abundant background colloid can
be easily mistaken as a benign adenomatoid colloid nodule
on cytology [16]. Even with surgery, differential diagnosis
between FA, minimally invasive FC, and FVPTC in a solitary,
encapsulated nodule showing follicular histology has been
problematic [6]. While there are several studies focusing
on ways to differentiate these neoplasms [5, 7, 15, 16], little
has been evaluated in association between the ultrasound
(US) features or the cytology results of USFNA within these
tumors. In this study, we evaluated the differences in US
features and the role of US-guided fine-needle aspiration
(USFNA) and intraoperative frozen section (FS) in FA, FC,
and FVPTC.
2. Materials and Methods
This retrospective study was approved by the institutional
review board (IRB) of Severance Hospital, Yonsei University,
Seoul, Republic of Korea. Neither patient approval nor
informed consent was required for review of medical records
or images. Informed consent was signed and obtained from
all patients before USFNA or surgery prior to procedures.
2.1. Study Population. From January 2003 to December 2008,
our institutional database was reviewed for patients diag-
nosedwith FA, FC, and FVPTC after surgical excision. A total
of 281 patients with 282 thyroid nodules were included in
this study. Among them, 51 patients were excluded because
they had either undergone USFNA at an outside clinic or
had not undergone preoperative cytologic diagnosis. In total,
230 patients with 231 thyroid nodules were included in
this study. Of the 230 patients, 45 (19.6%) were men, and
185 (80.4%) were women. Mean age of the 230 patients
included was 44.0 years. Mean size of the 231 thyroid nodules
was 27.3mm. Medical records, US images and radiological
reports, and cytopathologic reports of these patients were
reviewed, retrospectively.
2.2. US Imaging and Imaging Analyses. US was performed in
all patients using a 7–15MHz linear array transducer (HDI
3000 or 5000; Philips Medical Systems, Bothell, WA) or
a 5–12MHz linear array transducer (iU22; Philips Medical
System). Compound imaging was obtained in all images
using HDI5000 or iU22 machines.
Real-time US was performed by 1 of the 5 board-certified
radiologists with 1–13 years of experience in thyroid imaging.
US features of the thyroid nodules were retrospectively
reviewed and analyzed by one dedicated thyroid radiologist
(Y.J.H)with 3 years of experience.The radiologist was blinded
to the clinical and cytopathological information of the patient
during image review. US features of each thyroid nodule were
described according to internal components, echogenicity,
margin, calcifications, and shape [5]. Internal components
were divided into solid nodules, mixed solid, and cystic
nodules, that is, mainly solid nodules containing more than
50% of solid contents, mainly cystic nodules containing less
than 50% of solid contents, and cysts. Echogenicity was
divided into hyper or isoechoic (nodules showing hyperecho-
genicity or isoechogenicity compared with the adjacent nor-
mal thyroid parenchyma), hypoechoic (nodules showing
hypoechogenicity compared to the adjacent normal thyroid
parenchyma), and markedly hypoechoic (nodules showing
hypoechogenicity compared to the adjacent strap mus-
cle). Margin was classified as circumscribed or noncircum-
scribed (i.e., microlobulated or irregular margins). Calcifi-
cations were classified as microcalcifications (tiny, punctate,
echogenic foci measuring less than 1mm) [17] or mixed
microcalcifications with macrocalcifications, macrocalcifica-
tions (including eggshell calcifications), and no calcifications.
Shape was divided into parallel or nonparallel (greater in the
anteroposterior dimension than the transverse dimension,
or “taller-than-wide”). Malignant US features were defined
as marked hypoechogenicity, noncircumscribed margins,
microcalcifications or mixed calcifications, and nonparallel
shape, based on previously published criteria [18]. Final
assessments of the thyroid nodules were given as probably
benign (when none of the suspicious US features described
above was present) or suspicious malignant (when 1 or more
suspicious US features above were present).
2.3. USFNA and Cytological Analyses. USFNA was subse-
quently performed by the same radiologist who obtained
the real-time US images. USFNA was performed either on
the thyroid nodules showing suspicious US features or on
the nodule with the largest size without any suspicious US
features.
USFNA was performed at least twice from the targeted
thyroid nodule using a 23-gauge needle attached to a 20mL
disposable syringe with an aspirator or a 23-gauge needle
attached to a 2mL disposable syringe without an aspirator,
depending on the radiologist’s preference. Local anesthesia
was not routinely applied. Aspirated material was expelled
on to glass slides, smeared, and immediately placed in 95%
alcohol for Papanicolaou staining. The remaining material
in the syringe was rinsed in normal saline for cell block
processing. The cytopathologists were not present during
USFNA procedures, and additional staining was performed
on a case-by-case basis at the request of the cytopathologist.
One of the 5 cytopathologists specializing in thyroid
pathology interpreted the slides obtained from USFNA.
During the study period, cytologic reports were divided into
the following categories: (1) malignant, (2) suspicious for
malignant, (3) indeterminate, (4) benign, and (5) inadequate
[5, 19–21].Malignancy indicated specimen showing abundant
cells with unequivocal cytologic features of malignancy.
Suspicious for malignancy was used in specimen showing
cytologic atypia, that is, crowded, overlapping, pleomor-
phic, and enlarged nuclei, but with insufficient cellularity
for definite diagnosis of malignancy [19, 21]. Indeterminate
cytology included follicular neoplasm and Hu¨rthle cell neo-
plasm, indicating specimen showing monotonous cellular
population, scanty colloid, and lacking papillary carcinoma
features [22]. Benign cytology includes colloid nodules,
nodular hyperplasia, lymphocytic thyroiditis, Graves’ disease,
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and postpartum thyroiditis. Inadequate cytology indicates
specimen showing less than the required minimum of six
groupings of well-preserved thyroid cells, each consisting of
less than 10 cells per group [19, 20].
2.4. Surgical Procedures and Intraoperative Frozen Section.
The extent of surgery was performed based on the cytology
results andUS features. A lobectomy, subtotal thyroidectomy,
or total thyroidectomy was performed if cytology findings
were diagnosed as malignancy or suspicious for malignancy
or if the US features were assessed as suspicious malignant
in nodules with benign cytology diagnosis. A lobectomy,
or subtotal thyroidectomy, was performed if the cytology
results were benign. Of the cytology results was inadequate
or indeterminate, the extent of thyroid surgery was based on
intraoperative FS during surgery.
Tissue samples including the thyroid nodule and/or the
adjacent thyroid parenchyma were obtained and processed
for FS analyses. Frozen tissue samples were subsequently cut
and stained for diagnosis. After diagnosis was made, results
were notified to the operation room. Diagnosis was classified
into the following 3 categories in FS: (1)malignant, (2) benign,
and (3) deferred results, including follicular neoplasm [5, 21].
2.5. Statistical Analyses. Histopathologic results from surgery
were considered standard reference. In comparison to the
mean age and mean size of thyroid nodules on US among
the three neoplasms, Analysis of variance (ANOVA) test and
post hoc test was used. 𝜒2-test or Fisher’s exact test was used
in comparison to US features among the final pathology of
the disease. Diagnostic performances including sensitivity,
specificity, positive predictive value (PPV), negative predic-
tive value (NPV), and accuracy were calculated for USFNA
cytology and intraoperative FS results. In regard to USFNA,
inadequate cytology was excluded during calculation of diag-
nostic performances, considering benign cytology as negative
and indeterminate, suspicious formalignancy, andmalignant
cytology as positive. For comparison with intraoperative FS,
diagnostic performances of USFNA excluding both inade-
quate and indeterminate cytology were also calculated. In
regard to FS, deferred results were excluded when obtaining
diagnostic performances [5].
𝑃 value of less than 0.05 was considered significant. Sta-
tistical analysis was performed by the SAS system (MAGREE
SAS Macro program; SAS Institute, Cary, NC).
3. Results
Of the 231 thyroid lesions, 152 (65.8%) were diagnosed as
FA, 25 (10.8%) as FVPTC, and 54 (23.4%) as FC on surgical
pathology. Mean age and size among the three neoplasms are
summarized in Table 1. Mean age of the nodules diagnosed
as FC was the oldest, 47.2 ± 17.7 years, with statistical
significance (𝑃 = 0.042). When comparing FC to FA,
mean age was also significantly older in FC (𝑃 = 0.034).
No significant differences were observed in mean age when
comparing between FVPTC and FA or between FVPTC and
FC (𝑃 = 0.101 and 0.991, resp.). Mean size of the nodules
diagnosed as FVPTC was the smallest, 16.3 ± 14.6mm, with
statistical significance (𝑃 < 0.001). FVPTC was significantly
smaller than FA, 29.7 ± 14.5mm to 16.3 ± 14.6mm (𝑃 <
0.001), but tumor size between FC and FA did not show
statistical significance (𝑃 = 0.126).
US features of the 231 thyroid nodules are summarized
in Table 2. Of the 152 nodules diagnosed as FA, 136 (89.5%)
showed no suspicious US features. In contrast, 12 (48.0%)
of the 25 nodules diagnosed as FC and 28 (51.9%) of
the 54 nodules diagnosed as FVPTC showed one or more
suspicious US features. Lesions diagnosed as FC and FVPTC
showed significantly higher rates of suspicious US features
compared to FA (𝑃 < 0.001). Suspicious US features such as
hypoechogenicity or marked hypoechogenicity, noncircum-
scribed margins, presence of micro- or macrocalcifications,
or nonparallel orientation were significantly associated with
FC or FVPTC than FA (𝑃 < 0.05).
Results of USFNA cytology are summarized in Table 3
and Figure 1. Rate of inadequate cytology on USFNA was
higher in FA (18.4%) compared to FC (4.0%) and FVPTC
(7.4%). Also, rate of benign and indeterminate cytology was
relatively higher in FA (23.7% and 36.2%) and FC (24.0% and
52.0%) compared to FVPTC (5.6% and 7.4%, resp.). In con-
trast, rate of suspicious for malignancy and malignant cytol-
ogy was higher in FVPTC (31.5% and 48.1%) than FA (17.1%
and 4.6%) or FC (20.0% and 0.0%, resp.). When considering
each type of neoplasm, 88 of 152 (57.9%) nodules diagnosed
as FA, 18 of 25 (72.0%) nodules diagnosed as FC, and 47 of
54 (87.0%) nodules diagnosed as FVPTC were diagnosed as
indeterminate, suspicious for malignancy or malignancy on
cytology, showing statistical significance (𝑃 < 0.001).
Of the 231 thyroid nodules, 156 (67.5%) underwent intra-
operative FS (Table 3, Figure 2). Among them, 46 (29.5%)
were deferred to final pathology. Malignant results on intra-
operative FS significantly correlated to FC or FVPTC on final
pathology (𝑃 < 0.001). Two of the 15 nodules diagnosed as
FC and 4 of the 25 nodules diagnosed as FVPTC showed
false-negative results on intraoperative FS. Five of the 6
(83.3%) nodules showing false-negative FS were diagnosed as
suspicious for malignancy or malignancy on USFNA. Also,
3 of the 116 nodules diagnosed as FA showed false-positive
results on intraoperative FS.
Diagnostic performances of USFNA and intraoperative
FS are summarized in Table 4. Specificity of USFNA was low,
29.3%, when considering indeterminate cytology as positive.
Overall diagnostic performances of intraoperative FS were
higher than USFNA.
4. Discussion
Follicular adenomas are well-encapsulated thyroid neo-
plasms which do not show the typical invasiveness of follic-
ular carcinoma, nor abnormal nuclear features of papillary
carcinomas [7]. FA and FC, along with FVPTC, are well-
encapsulated lesions, sharing many imaging and cytologic
features, and show relatively benign US features [7, 23, 24]. In
our study, tumor size of FVPTCwas significantly smaller than
FC or FA, 16.3mm to 36.4mm and 29.7mm, respectively. As
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Table 1: Comparison ofmean age and size among the 231 thyroid nodules diagnosed as follicular adenoma, follicular carcinoma, and follicular
variant of papillary thyroid carcinoma.
Pathology 𝑁 Age (years) 𝑃 Size (mm) 𝑃
Mean ± SD Min Max 0.042 Mean ± SD Min Max <0.001
FA 152 42.5 ± 12.8 19.0 72.0 — 29.7 ± 14.5 6.0 73.0 —
FC 25 47.2 ± 17.7 15.0 78.0 0.230∗ 36.4 ± 20.2 13.0 100.0 0.126∗
FVPTC 54 46.9 ± 9.9 27.0 64.0 0.101∗ 16.3 ± 14.6 3.0 100.0 <0.001∗
FA: follicular adenoma.
FC: follicular carcinoma.
FVPTC: follicular variant papillary thyroid carcinoma.
𝑁: number of cases.
SD: standard deviation.
∗values when compared to follicular adenoma.
Table 2: Comparison of US features among the 231 thyroid nodules diagnosed as follicular adenoma, follicular carcinoma, and follicular
variant of papillary thyroid carcinoma.
US features Pathology Total 𝑃
FA (𝑛 = 152) FC (𝑛 = 25) FVPTC (𝑛 = 54)
Composition 0.033
Solid 110 (72.4) 17 (68.0) 49 (90.7) 176 (76.2)
Mainly solid 38 (25.0) 6 (24.0) 4 (7.4) 48 (20.8)
Mainly cystic 4 (2.6) 2 (8.0) 1 (1.9) 7 (3.0)
Echogenicity <0.001
Hyper/isoechoic 94 (61.8) 9 (36.0) 12 (22.2) 115 (49.8)
Hypoechoic 58 (38.2) 14 (56.0) 42 (77.8) 114 (49.3)
Markedly hypoechoic 0 (0.0) 2 (8.0) 0 (0.0) 2 (0.9)
Margin <0.001
Circumscribed 143 (94.1) 20 (80.0) 30 (55.6) 193 (83.5)
Noncircumscribed 9 (5.9) 5 (20.0) 24 (44.4) 38 (16.5)
Calcifications <0.001
Micro- or mixed 1 (0.7) 3 (12.0) 7 (13.0) 11 (4.8)
Macro- or eggshell 12 (7.9) 4 (16.0) 13 (24.0) 29 (12.6)
Negative 139 (91.4) 18 (72.0) 34 (63.0) 191 (82.6)
Shape 0.006
Parallel 149 (98.0) 23 (92.0) 47 (87.0) 219 (94.8)
Nonparallel 3 (2.0) 2 (8.0) 7 (13.0) 12 (5.2)
Final assessment <0.001
Probably benign 136 (89.5) 13 (52.0) 26 (48.1) 175 (75.8)
Suspicious malignant 16 (10.5) 12 (48.0) 28 (51.9) 56 (24.2)
Note: percentages are in parentheses.
mentioned above, thyroid lesions of follicular pattern tend to
represent more benign features on US and, therefore, may
have not undergone diagnostic procedures such as USFNA
unless they have reached sizes over 10mm or until they
have grown to sizes that may have brought about clinical
significance such as presence of symptoms.
Common suspicious US features such as microlobulated
or irregular margins, marked hypoechogenicity, taller-than-
wide shape, and presence of microcalcifications are used
in differentiating papillary thyroid carcinoma with high
diagnostic accuracy but do not seem to work the same
when differentiating between lesions of follicular patterns
[10]. US features reported for follicular neoplasm or FVPTC
are relatively benign appearing, showing well-defined, solid
mass with oval shape, surrounding hypoechoic rim [10, 15,
23, 25], among which findings do not significantly differ
between benign FA or malignant FC or FVPTC. Our results
showed that 52.0% of FC and 48.1% of FVPTC had no
suspicious US features, consistent with other reports in that
malignant form of follicular neoplasm has relatively benign
appearance on US. However, several suspicious US features
of papillary thyroid carcinoma such as microlobulated or
ill-definedmargins, microcalcifications, and taller-than-wide
shape have been reported to be more significantly seen in the
malignancy among nodules showing indeterminate cytology
[5]. In our results, suspicious US features were significantly
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Table 4: Diagnostic performances of USFNA and intraoperative
frozen section.
(%) FNA∗ FNA† FS‡
Sensitivity 87.8 (65/74) 84.2 (48/57) 80.0 (24/30)
Specificity 29.0 (36/124) 52.2 (36/69) 96.3 (77/80)
PPV 42.5 (65/153) 59.3 (48/81) 88.9 (24/27)
NPV 80.0 (36/45) 80.0 (36/45) 92.8 (77/83)
Accuracy 51.0 (101/198) 66.7 (84/126) 91.8 (101/110)
FNA: fine needle aspiration; FS: frozen section; PPV: positive predictive
value; NPV: negative predictive value.
Note: raw data are in parenthesis.
∗Inadequate cytology results excluded, indeterminate, suspicious for malig-
nancy and malignant cytology results considered positive.
†Inadequate and indeterminate cytology results excluded.
‡46 nodules excluded due to deferred results on FS.
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Figure 1: Results of USFNA cytology of the 231 thyroid nodules.
Note: numbers in image represent percentages (%).
associated with FC or FVPTC than FA. Although FC or
FVPTC do not show the typical suspicious US features as
frequently as conventional PTC, the presence of each indi-
vidual US features may have a role in leading the radiologists
or clinicians in differentiating these lesions from FA.
While USFNA is widely used in discriminating between
benign and malignancy in various lesions of the thyroid
showing excellent performances (sensitivity 65%–98%, speci-
ficity 72%–100%) [3, 5, 26, 27] this has limited value in
the differential diagnosis of follicular neoplasm, in which
USFNA is considered only as a “screening test” [28]. Nodules
diagnosed as follicular neoplasm or suspicious for follicular
neoplasm on cytology mostly undergo surgery for diagnostic
purposes, but the true role of USFNA cytology results in pre-
dicting diagnosis of follicular neoplasmhas not been clarified.
Indeed, sensitivity of USFNA in the diagnosis of FVPTC has
been reported to be lower than PTC, ranging from 25.0%
to 32.0% [13, 15, 29, 30]. Cytologic diagnosis of follicular
patterned lesions of the thyroid with USFNA is imprecise,
although one can predict a diagnosis but cannot reach a final
conclusion based on cytology alone [1]. Results of our study
showed higher rates of benign cytology in FA (23.7%) and
FC (24.0%) compared to FVPTC (5.6%). Cytology specimen
showing multinodular process with intervening colloid-rich
thyroid tissue is often seen not only in follicular neoplasm
but also in benign adenomatoid nodules [1, 31], which may
have been a cause for false-negative results. Another cause
for benign cytology results in FC may be failure to sample
in FC with cystic areas [32]. Nearly 32.0% of FC included
in our study revealed cystic portions within the tumor on
preoperative US, which may have been one of the causes for
benign results on USFNA.
The diagnosis rate of FVPTC on USFNA cytology is
low in clinical practice, ranging from 9.0% to 36.0% [13, 33,
34]. Unlike conventional papillary carcinoma, the presence
of abundant colloid, subtle nuclear features of papillary
carcinoma, and the absence of papillary formations and
psammomatous bodies are the known causes that interfere
with the definite diagnosis on cytology [22, 32]. But a recent
study suggested that some cytologic features of conventional
PTC such as fine chromatic, nuclear grooving, and intranu-
clear inclusions are present at high frequency in FVPTC [13].
Although present with a wide variance, these specific features
may help in classifying FVPTC towards indeterminate or
suspicious for papillary carcinoma which is enough to lead
towards surgical management [13]. Our study showed higher
rates of suspicious for malignancy or malignant cytology
results in FVPTC (31.5% and 48.1%) than FA (17.1% and 4.6%)
or FC (20.0% and 0.0%), and the cytology features of FVPTC
mentioned above may have contributed to these results. In
addition, cystic changes, hemorrhage, and degeneration of
collagen can be found in FA [35–37], and along with the
typical “spoke and wheel” vascularity pattern characteristic
for FA may have been the causes for high rates of inadequate
cytology (18.4%) compared to FC (4.0%) and FVPTC (7.4%)
[37, 38].
Intraoperative FS has been popularly used in the diagno-
sis of thyroid nodules, having an important role in deciding
the surgical extent based on its results [39, 40]. Although
it is not useful in the differential diagnosis of benign to
malignant thyroid nodules [21, 41], it is often used as a
supplement to preoperative USFNA. Controversy remains in
the role of intraoperative FS in follicular neoplasm. Some
proved increased specificity, but lower sensitivity compared
to USFNA, diagnostic accuracy ranging from 50% to 98% [5,
42–44], while others claim that FS does not effectively provide
any additional information in the diagnosis of follicular
neoplasm [45]. In one study on USFNA and FS, both FNA
and FS were highly accurate in predicting final pathology
when the diagnosis was papillary carcinoma or benign but
missed 44% of the malignancies in follicular lesions [39].
Diagnostic performances of intraoperative FS when exclud-
ing the deferred results in our study showed high sensitivity
(80.0%), specificity (96.3%), and accuracy (91.8%), showing
better performances than USFNA as in a recent report [44].
FVPTC and FC showed significantly highermalignant results
in intraoperative FS, 81.8% and 75.0%, respectively, compared
to FA, 3.8%. These results are similar to a previous study
suggesting that with intraoperative FS, nearly 52% to 60%
of the malignant subtype of follicular neoplasm do not
International Journal of Endocrinology 7
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Figure 2: Results of intraoperative frozen section of the 231 thyroid nodules. Note: numbers in image represent percentages (%).
require secondary procedures [44]. Also, among the nodules
showing false-negative intraoperative FS results, 83.3% (5 of
6 diagnosed as benign on FS, Table 3) were diagnosed as
suspicious for malignancy or malignancy on USFNA, which
further supports the complementary relation of USFNA and
intraoperative FS in lesions of follicular pattern in thyroid
[39].
There are several limitations to our study. First, this study
was in a retrospective design, including patients diagnosed as
FA, FC, or FVPTCon surgery. Selection biasmay have existed
in patient inclusion. Second, 5 cytopathologists were involved
in interpretation of cytology, intraoperative FS, and final
pathologic diagnosis. Observer variability on the diagnosis of
follicular neoplasmmay have affected the results of our study
[1]. Third, vascularity of the nodule on Doppler US was not
considered in the analysis of US features among the subtypes
of follicular neoplasm included in this study. Controversy
remains in the role of vascularity on US in the diagnosis of
thyroid nodules [46, 47], and how it would apply to follicular
neoplasm is yet to be explained.
In conclusion, suspicious US features were more signifi-
cantly seen in FC and FVPTC compared to FA. Intraoperative
FS is useful in the differential diagnosis of these lesions and
supplements cytology results of USFNA.
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